Edition:
United Kingdom

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

1.60USD
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
$1.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
73,394
52-wk High
$7.84
52-wk Low
$0.99

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Howard Yeaton

63 2018 Chief Executive Officer, Interim Chief Financial Officer

John Cheneval

2015 Executive Vice President, Sales and Marketing

Gary Rauch

59 2014 Senior Vice President - Finance, Treasurer

Christopher Ellis

2015 Vice President - Global Marketing

Christopher Schreiber

53 2017 Director